TLR4 and neoplasm: We used TLR4 ligand LPS, TLR3 ligand polyI:C and the Jonuleit cytokine cocktail most commonly used in today’s DC-based tumor vaccines consisting of IL-1β, IL-6, TNF-α and PGE2[42] for the generation of immunogenic DC.